Study Evaluates Gilenya's Impact on Central Autonomic Dysfunction In MS With Delayed Heart Rate
In a recent study published in the Journal PLOS One, a team of researchers found that the autonomic cardiovascular dysfunction in MS patients with delayed heart ratere-acceleration upon Fingolimod-initiation suggest that MS-related central autonomic lesions may compromise heart rate re-acceleration.
Continue Reading http://multiplesclerosisnewstoday.com
Join the Discussion